G1 Therapeutics | 4:持股变动声明-高管 Thomas Monica R.
G1 Therapeutics | 4:持股变动声明-高管 Perry Andrew
G1 Therapeutics | 4:持股变动声明-高管 MURDOCK TERRY L
G1 Therapeutics | 4:持股变动声明-高管 Bailey John E. (Jack) Jr.
G1 Therapeutics | 4:持股变动声明-高管 Malik Rajesh
G1 Therapeutics | 4:持股变动声明-高管 Umstead John W. V
G1 Therapeutics | 4:持股变动声明-高管 Avagliano Mark
G1 Therapeutics | 4:持股变动声明-高管 Avagliano Mark
G1 Therapeutics | 4:持股变动声明-高管 Thomas Monica R.
G1 Therapeutics | 4:持股变动声明-高管 Umstead John W. V
G1 Therapeutics | 4:持股变动声明-高管 Umstead John W. V
G1 Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fredric N. Eshelman(9.26%),Eshelman Ventures, LLC(8.13%)
G1 Therapeutics | 4:持股变动声明-高管 Malik Rajesh
G1 Therapeutics | 4:持股变动声明-高管 Umstead John W. V
G1 Therapeutics | 4:持股变动声明-高管 Malik Rajesh
G1 Therapeutics | 4:持股变动声明-高管 Perry Andrew
G1 Therapeutics | 4:持股变动声明-高管 Thomas Monica R.
G1 Therapeutics | 4:持股变动声明-高管 Avagliano Mark
G1 Therapeutics | 4:持股变动声明-高管 Bailey John E. (Jack) Jr.
G1 Therapeutics | 4:持股变动声明-高管 MURDOCK TERRY L
暂无数据